Lupin

Pharma

Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia

Enhertu delivered a positive readout in first-line breast cancer. Akeso's ivonescimab bagged another phase 3 win. Fujifilm signed a 10-year deal with Regeneron.

Angus Liu Apr 25, 2025 8:45am

Lupin recalls nearly 3,000 bottles of OCD drug in US

Apr 24, 2025 9:48am

Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia

Dec 6, 2024 9:00am

Lupin recalls 600K bottles of blood pressure med

Nov 25, 2024 1:20pm

MediLink, Takeda, Ascentage and China NMPA—Fierce Pharma Asia

Jun 21, 2024 8:23am

Lupin names CEO for its newly announced CDMO arm

Jun 17, 2024 2:54pm